NON-MUSCLE INVASIVE BLADDER CANCER: Edited by Ashish M. Kamat and Paolo GonteroCurrent concept of transurethral resection of bladder cancer from re-transurethral resection of bladder cancer to en-bloc resectionSchraml, Jana,b; Silva, Joana Do Carmob; Babjuk, Markob,aAuthor Information aDepartment of Urology, Masaryk Hospital, Ústí nad Labem bDepartment of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Praha, Czech Republic Correspondence to Marko Babjuk, Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, V Úvalu 84, 15006, Praha 5, Czech Republic. Tel: +420 224434801; e-mail: [email protected] Current Opinion in Urology: November 2018 - Volume 28 - Issue 6 - p 591-597 doi: 10.1097/MOU.0000000000000542 Buy Metrics Abstract Purpose of review Transurethral resection of bladder cancer (TURB) is the critical step in the management of nonmuscle invasive bladder cancer (NMIBC). This review presents new improvements in the strategy and technique of TURB as well as in technological developments used for tumour visualization and removal. Recent findings The goal of TURB is to perform complete resection of NMIBC. Tumor visualization during procedure can be improved by enhanced optical technologies. Fluorescence-guided photodynamic diagnosis (PDD) and narrow-band imaging (NBI) used during TURB can improve tumour detection and potentially reduce recurrence rate, their influence on progression, however, remains controversial. TURB can be performed using monopolar or bipolar electrocautery without significant differences in results or safety. To overcome limitations of traditional TURB, the technique of en-bloc resection was introduced to improve the quality of tumour removal. In selected cases, an early re-resection (re-TURB) within 2–6 weeks after initial procedure is recommended. Summary TURB is a fundamental step in diagnosis and treatment of NMIBC. Urologists should be aware of promising innovations including new imaging and surgical techniques and their potential benefits. Hopefully, new technologies and performance of TURB bring improved outcomes, which can alter the indication criteria for re-TURB. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.